Your browser doesn't support javascript.
loading
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
Martín, Miguel; Carrasco, Eva; Rodríguez-Lescure, Álvaro; Andrés, Raquel; Servitja, Sonia; Antón, Antonio; Ruiz-Borrego, Manuel; Bermejo, Begoña; Guerrero, Ángel; Ramos, Manuel; Santaballa, Ana; Muñoz, Montserrat; Cruz, Josefina; Lopez-Tarruella, Sara; Chacón, Jose I; Álvarez, Isabel; Martínez, Purificación; Miralles, Juan J; Polonio, Óscar; Jara, Carlos; Aguiar-Bujanda, David.
Affiliation
  • Martín M; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain. mmartin@geicam.org.
  • Carrasco E; GEICAM, Spanish Breast Cancer Group, Madrid, Spain. mmartin@geicam.org.
  • Rodríguez-Lescure Á; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. mmartin@geicam.org.
  • Andrés R; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.
  • Servitja S; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.
  • Antón A; Hospital General Universitario de Elche, Elche, Spain.
  • Ruiz-Borrego M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.
  • Bermejo B; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
  • Guerrero Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.
  • Ramos M; Hospital del Mar, Barcelona, Spain.
  • Santaballa A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.
  • Muñoz M; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.
  • Cruz J; Hospital Universitario Miguel Servet, Universidad de Zaragoza, Instituto Investigación Sanitaria Aragón (IISA), Zaragoza, Spain.
  • Lopez-Tarruella S; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.
  • Chacón JI; Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Álvarez I; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.
  • Martínez P; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.
  • Miralles JJ; Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA. Universidad de Valencia, Valencia, Spain.
  • Polonio Ó; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.
  • Jara C; Instituto Valenciano de Oncología, Valencia, Spain.
  • Aguiar-Bujanda D; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.
Breast Cancer Res Treat ; 201(2): 151-159, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37338729
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2023 Document type: Article Affiliation country: Country of publication: